Vantas

   
Google
 
Web NewDrugInformation.com

Vantas


Drug - Vantas
The trade name of the product as shown on the labeling.

Dosage - IMPLANT; SUBCUTANEOUS
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Histrelin Acetate
Multiple ingredients are in alphabetical order.

Strength - 50MG
The potency of the active ingredient(s), Histrelin Acetate. May repeat for multiple part products.

Applicant - VALERA
The firm name holding legal responsibility for Vantas. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021732
The FDA assigned number to Vantas. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Vantas. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 12, 2004
The date Vantas was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Vantas. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Vantas is in. Format is RX, OTC, DISCN.

Applicant Full Name - Valera Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Vantas.

Vantas